2013 annual financial data
Vistagen Therapeutics 2013 Financial results
Direct answer
Revenue was 200,400 USD.
Operating income was -6,793,100 USD and net income was -12,886,700 USD.
Operating cash flow was -3,463,200 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 200,400 USD
- Operating income
- -6,793,100 USD
- Net income
- -12,886,700 USD
- Operating cash flow
- -3,463,200 USD
Explore related company data
View all 2013 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Vistagen Therapeutics financial years